MYUNGMOON Pharm co.,Ltd (KRX:017180)

South Korea · Delayed Price · Currency is KRW

1,871.00

-42.00 (-2.20%)

Feb 26, 2026, 12:27 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pharmaceutical Sector	200.14B	179.08B	173.97B	160.50B	128.39B
Pharmaceutical Sector Growth	11.76%	2.94%	8.39%	25.01%	-11.95%
Inter Segment Sales	-21.27B	-18.07B	-30.58B	-30.31B	-6.39B
Services Segment	7.57B	8.57B	8.75B	7.57B	5.85B
Services Segment Growth	-11.62%	-2.06%	15.56%	29.30%	21.50%
Total	186.44B	169.57B	152.13B	137.76B	127.85B
Total Growth	9.95%	11.46%	10.43%	7.75%	-14.39%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
South Korea	182.37B	165.88B	148.44B	133.05B	122.65B
South Korea Growth	9.94%	11.74%	11.57%	8.48%	-14.65%
Overseas	4.08B	3.69B	3.69B	4.71B	5.20B
Overseas Growth	10.46%	0%	-21.62%	-9.48%	-7.86%
Total	186.44B	169.57B	152.13B	137.76B	127.85B
Total Growth	9.95%	11.46%	10.43%	7.75%	-14.39%

Source: S&P Global Market Intelligence.